Post-transplantation lymphoproliferative disorders in adults

Research output: Contribution to journalReview articlepeer-review

109 Scopus citations


POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PPTLDS) ARE defined as lymphomas that occur after transplantation (Fig. 1). Recipients of solid-organ or allogeneic hematopoietic stem-cell transplants have an increased risk of cancers related to immunosuppression and the Epstein-Barr virus (EBV) - in particular, lymphomas.1,2 Although lymphoproliferative disorders were initially reported to be a rare complication of transplantation, observations during the past decade have shown that they are not uncommon and are associated with poor outcomes. Lymphoma accounts for 21% of all cancers in recipients of solidorgan transplants, as compared with 4% among women and 5% among men in an immunocompetent population.3 Important advances in diagnosis and treatment have been made after two consensus conferences.4,5 This review outlines our current understanding of the epidemiology of and risk factors for PTLD, the pathogenesis of these disorders, and current approaches to diagnosis, staging, and treatment.

Original languageEnglish (US)
Pages (from-to)549-562
Number of pages14
JournalNew England Journal of Medicine
Issue number6
StatePublished - Feb 8 2018

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Post-transplantation lymphoproliferative disorders in adults'. Together they form a unique fingerprint.

Cite this